Bayer Targets Lilly In False Ad Suit Over Pet Drugs

Law360, New York (May 5, 2011, 8:13 PM EDT) -- Bayer HealthCare LLC sued Eli Lilly & Co. in New York on Wednesday for allegedly engaging in false advertising and unfair competition in the pet medicine market that cost Bayer more than 1,000 veterinary accounts worth millions of dollars.

Bayer is accusing Lilly’s Elanco division, which directly competes with Bayer’s animal health division, of embarking on an unlawful campaign to convince distribution agents and veterinarians to stop selling Bayer’s flea and tick preventatives Advantage II and K9 Advantix II by claiming that Bayer’s sale of pet...
To view the full article, register now.




Case Information

Case Title

Bayer Healthcare LLC v. Eli Lilly and Company

Case Number



New York Southern

Nature of Suit

Other Statutory Actions


Alvin K. Hellerstein

Date Filed

May 4, 2011

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.